tiprankstipranks
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market
AGY
Allergy Therapeutics
RESEARCH TOOLSreports
Want to see GB:AGY full AI Analyst Report?

Allergy Therapeutics (AGY) Ratios

18 Followers

Allergy Therapeutics Ratios

GB:AGY's free cash flow for Q2 2026 was £0.53. For the 2026 fiscal year, GB:AGY's free cash flow was decreased by £ and operating cash flow was £-0.33. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 1.13 1.28 1.63 1.81 2.35
Quick Ratio
 0.70 0.76 1.01 1.18 1.72
Cash Ratio
 0.31 0.47 0.63 0.80 1.14
Solvency Ratio
 -0.67 -0.38 -0.59 -0.60 -0.27
Operating Cash Flow Ratio
 -1.02 -1.06 -1.56 -1.67 -0.78
Short-Term Operating Cash Flow Coverage
 -72.88 -70.91 -53.56 -47.71 -14.82
Net Current Asset Value
£ -30.50M£ -61.06M£ -27.64M£ -31.18M£ 7.21M
Leverage Ratios
Debt-to-Assets Ratio
 0.38 0.89 0.48 0.54 0.14
Debt-to-Equity Ratio
 6.30 -2.13 8.35 17.42 0.28
Debt-to-Capital Ratio
 0.86 1.88 0.89 0.95 0.22
Long-Term Debt-to-Capital Ratio
 0.82 2.13 0.86 0.93 0.04
Financial Leverage Ratio
 16.71 -2.40 17.48 32.32 1.93
Debt Service Coverage Ratio
 -4.02 -4.02 -7.10 -12.15 -6.57
Interest Coverage Ratio
 -4.41 -4.31 -9.09 -14.28 -24.03
Debt to Market Cap
 0.04 0.14 0.13 3.85 <0.01
Interest Debt Per Share
 <0.01 0.01 <0.01 0.06 0.02
Net Debt to EBITDA
 -0.51 -1.61 -0.59 -0.58 1.15
Profitability Margins
Gross Profit Margin
41.17%45.65%53.87%54.86%67.27%
EBIT Margin
-64.79%-61.04%-63.51%-67.91%-17.67%
EBITDA Margin
-57.12%-53.46%-55.69%-60.82%-11.94%
Operating Profit Margin
-60.23%-53.60%-63.87%-58.49%-17.87%
Pretax Profit Margin
-84.50%-73.48%-70.95%-71.53%-18.41%
Net Profit Margin
-85.46%-72.91%-72.86%-72.28%-18.93%
Continuous Operations Profit Margin
-85.46%-72.91%-72.86%-72.28%-18.93%
Net Income Per EBT
101.14%99.23%102.68%101.05%102.83%
EBT Per EBIT
140.29%137.08%111.09%122.30%103.05%
Return on Assets (ROA)
-68.96%-59.42%-62.04%-64.51%-18.88%
Return on Equity (ROE)
409.00%142.35%-1084.28%-2084.75%-36.48%
Return on Capital Employed (ROCE)
-88.54%-73.12%-79.62%-72.30%-23.68%
Return on Invested Capital (ROIC)
-84.29%-69.33%-75.99%-69.69%-22.74%
Return on Tangible Assets
-73.30%-63.41%-66.87%-72.97%-21.34%
Earnings Yield
-8.64%-10.59%-22.86%-612.38%-0.10%
Efficiency Ratios
Receivables Turnover
 5.22 6.90 7.06 8.41 6.95
Payables Turnover
 2.42 6.66 6.34 6.58 5.56
Inventory Turnover
 2.44 2.15 2.00 2.32 2.09
Fixed Asset Turnover
 2.17 2.27 2.32 2.56 3.60
Asset Turnover
 0.81 0.81 0.85 0.89 1.00
Working Capital Turnover Ratio
 9.79 5.39 3.96 3.03 2.28
Cash Conversion Cycle
 68.19 167.85 176.86 145.24 161.76
Days of Sales Outstanding
 69.96 52.86 51.73 43.42 52.51
Days of Inventory Outstanding
 149.29 169.79 182.69 157.33 174.88
Days of Payables Outstanding
 151.06 54.80 57.56 55.50 65.63
Operating Cycle
 219.25 222.65 234.42 200.74 227.39
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.05 -0.02
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.05 -0.03
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.14 1.11 1.11 1.15 1.22
Dividend Paid and CapEx Coverage Ratio
 -7.21 -8.80 -9.45 -6.62 -4.62
Capital Expenditure Coverage Ratio
 -7.21 -8.80 -9.45 -6.62 -4.62
Operating Cash Flow Coverage Ratio
 -1.23 -0.48 -1.04 -0.86 -1.34
Operating Cash Flow to Sales Ratio
 -0.57 -0.52 -0.58 -0.52 -0.19
Free Cash Flow Yield
-6.83%-8.44%-20.20%-505.95%-0.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.67 -9.44 -4.37 -0.16 -968.54
Price-to-Sales (P/S) Ratio
 8.80 6.88 3.19 0.12 183.36
Price-to-Book (P/B) Ratio
 122.96 -13.44 47.44 3.40 353.31
Price-to-Free Cash Flow (P/FCF) Ratio
 -13.50 -11.85 -4.95 -0.20 -777.22
Price-to-Operating Cash Flow Ratio
 -15.93 -13.20 -5.47 -0.23 -945.55
Price-to-Earnings Growth (PEG) Ratio
 0.76 0.44 0.05 >-0.01 1.68
Price-to-Fair Value
 122.96 -13.44 47.44 3.40 353.31
Enterprise Value Multiple
 -15.92 -14.48 -6.31 -0.78 -1.53K
Enterprise Value
 563.72M 426.23M 194.01M 28.18M 13.33B
EV to EBITDA
 -17.22 -14.48 -6.31 -0.78 -1.53K
EV to Sales
 9.84 7.74 3.51 0.47 183.22
EV to Free Cash Flow
 -15.10 -13.33 -5.46 -0.79 -776.64
EV to Operating Cash Flow
 -17.19 -14.84 -6.04 -0.91 -944.84
Tangible Book Value Per Share
 <0.01 >-0.01 >-0.01 >-0.01 0.05
Shareholders’ Equity Per Share
 <0.01 >-0.01 <0.01 <0.01 0.06
Tax and Other Ratios
Effective Tax Rate
 -0.01 <0.01 -0.03 -0.03 -0.08
Revenue Per Share
 0.01 0.01 0.01 0.09 0.11
Net Income Per Share
 >-0.01 >-0.01 -0.01 -0.06 -0.02
Tax Burden
 1.01 0.99 1.03 1.01 1.03
Interest Burden
 1.30 1.20 1.12 1.05 1.04
Research & Development to Revenue
 0.29 0.28 0.41 0.34 0.22
SG&A to Revenue
 0.76 0.70 0.41 0.42 0.29
Stock-Based Compensation to Revenue
 0.00 0.02 0.00 <0.01 <0.01
Income Quality
 0.67 0.73 0.80 0.72 1.02
Currency in GBP